ENTBF (Entheon Biomedical) Total Equity: $0.16 Mil (As of Feb. 2026)


What is Entheon Biomedical Total Equity?

Entheon Biomedical ENTBF Total Equity is $0.16 Mil as of Feb. 2026. The stock has 2 warning signs investors should review.

Entheon Biomedical's total equity for the quarter that ended in Feb. 2026 was $0.16 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Entheon Biomedical Total Equity Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Total Equity Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
Total Equity
Get a 7-Day Free Trial Premium Member Only 7.20 0.46 0.23 0.10 0.23

Entheon Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.31 0.28 0.23 0.16

Entheon Biomedical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Entheon Biomedical's Total Equity for the fiscal year that ended in Nov. 2025 is calculated as

Total Equity=Total Assets(Q: Nov. 2025 )-Total Liabilities(Q: Nov. 2025 )
=0.252-0.021
=0.23

Entheon Biomedical's Total Equity for the quarter that ended in Feb. 2026 is calculated as

Total Equity=Total Assets(Q: Feb. 2026 )-Total Liabilities(Q: Feb. 2026 )
=0.208-0.044
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $0.16 Mil mean?
Entheon Biomedical (ENTBF) has a Total Equity of $0.16 Mil as of Feb. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Entheon Biomedical and its competitors.
Is Entheon Biomedical's Total Equity too high?
Entheon Biomedical's current Total Equity is $0.16 Mil.
How does Entheon Biomedical's Total Equity compare to VRTX and REGN?
Entheon Biomedical's Total Equity of $0.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Entheon Biomedical and its competitors. Entheon Biomedical's current Total Equity is $0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Total Equity of $0.16 Mil. The current Total Equity is $0.16 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Total Equity is $0.16 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.